NCT05980481 2025-09-29
A Study of RC48-ADC Combination Therapies as First-line Treatment in Advanced Metastatic Gastric Cancer
RemeGen Co., Ltd.
Phase 2/3 Active not recruiting
RemeGen Co., Ltd.
Australasian Gastro-Intestinal Trials Group
Ono Pharmaceutical Co. Ltd
Shanghai University of Traditional Chinese Medicine
Ruijin Hospital